{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "goodwill-and-reputation", "type": "clause", "offset": [28, 51]}, {"key": "associated-with", "type": "definition", "offset": [66, 81]}, {"key": "other-party", "type": "definition", "offset": [86, 97]}, {"key": "consistent-with", "type": "clause", "offset": [233, 248]}, {"key": "trademark-guidelines", "type": "definition", "offset": [249, 269]}, {"key": "reasonable-precautions", "type": "clause", "offset": [297, 319]}, {"key": "reasonably-likely", "type": "definition", "offset": [461, 478]}], "snippet": "Each Party acknowledges the goodwill and reputation that has been associated with the other Party\u2019s Housemarks over the years, and shall use such Housemarks in a manner that maintains and promotes such goodwill and reputation and is consistent with trademark guidelines. Each Party shall take all reasonable precautions and actions to protect the goodwill and reputation that has inured to the other Party\u2019s Housemarks, shall refrain from doing any act that is reasonably likely to impair the reputation of such Housemarks, and shall cooperate fully to protect such Housemarks.", "samples": [{"hash": "3NFTaWmyekj", "uri": "/contracts/3NFTaWmyekj#housemarks", "label": "Commercialization Agreement", "score": 31.340862423, "published": true}, {"hash": "lDGiyHWCaAy", "uri": "/contracts/lDGiyHWCaAy#housemarks", "label": "Collaboration Agreement (Theravance Inc)", "score": 25.5968514716, "published": true}, {"hash": "liGGNcK8fiU", "uri": "/contracts/liGGNcK8fiU#housemarks", "label": "Commercialization Agreement (Theravance Biopharma, Inc.)", "score": 25.3449691992, "published": true}], "size": 8, "hash": "fdbeba62b81dccc887fedf209dc6359e", "id": 1}, {"snippet_links": [{"key": "neither-party-shall", "type": "clause", "offset": [0, 19]}, {"key": "affiliates-and-sublicensees", "type": "clause", "offset": [47, 74]}, {"key": "use-of-the-trademarks", "type": "clause", "offset": [94, 115]}, {"key": "house-marks", "type": "clause", "offset": [119, 130]}, {"key": "other-party", "type": "definition", "offset": [138, 149]}, {"key": "corporate-names", "type": "definition", "offset": [198, 213]}], "snippet": "Neither Party shall, and shall ensure that its Affiliates and sublicensees will not, make any use of the trademarks or house marks of the other Party or its Affiliates or licensees (including their corporate names) or any trademark confusingly similar thereto.", "samples": [{"hash": "as5YRln7rA4", "uri": "/contracts/as5YRln7rA4#housemarks", "label": "Option for a License Agreement (Macrogenics Inc)", "score": 24.7563312799, "published": true}, {"hash": "4XXeMTJu56g", "uri": "/contracts/4XXeMTJu56g#housemarks", "label": "Option for a License Agreement (Macrogenics Inc)", "score": 24.7563312799, "published": true}, {"hash": "gwnFq6CKuKM", "uri": "/contracts/gwnFq6CKuKM#housemarks", "label": "Option for a License Agreement (Macrogenics Inc)", "score": 24.6741957563, "published": true}], "size": 4, "hash": "da7cbbbf822c88c6a92a94559374a8c7", "id": 2}, {"snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "licenses-and-covenants", "type": "clause", "offset": [40, 62]}, {"key": "in-respect-of", "type": "clause", "offset": [63, 76]}, {"key": "other-party", "type": "definition", "offset": [111, 122]}, {"key": "the-joint-steering-committee", "type": "clause", "offset": [152, 180]}, {"key": "prior-to-commercialization", "type": "clause", "offset": [192, 218]}, {"key": "the-applicable", "type": "clause", "offset": [222, 236]}, {"key": "alliance-product", "type": "definition", "offset": [237, 253]}, {"key": "goodwill-and-reputation", "type": "clause", "offset": [315, 338]}, {"key": "associated-with", "type": "definition", "offset": [353, 368]}, {"key": "consistent-with", "type": "clause", "offset": [520, 535]}, {"key": "trademark-guidelines", "type": "definition", "offset": [536, 556]}, {"key": "reasonable-precautions", "type": "clause", "offset": [625, 647]}, {"key": "reasonably-likely", "type": "definition", "offset": [789, 806]}], "snippet": "Each Party shall enter into appropriate licenses and covenants in respect of its or its Affiliates' use of the other Party's Housemarks at such time as the Joint Steering Committee determines prior to Commercialization of the applicable Alliance Product. Such licenses shall ensure that each Party acknowledges the goodwill and reputation that has been associated with the other Party's Housemarks over the years, and shall use such Housemarks in a manner that maintains and promotes such goodwill and reputation and is consistent with trademark guidelines. Further, such licenses shall ensure that each Party shall take all reasonable precautions and actions to protect the goodwill and reputation that has inured to the other Party's Housemarks, shall refrain from doing any act that is reasonably likely to impair the reputation of such Housemarks, and shall cooperate fully to protect such Housemarks.", "samples": [{"hash": "hbpcZjXzri4", "uri": "/contracts/hbpcZjXzri4#housemarks", "label": "Strategic Alliance Agreement (Theravance Inc)", "score": 21.0, "published": true}, {"hash": "fEJWd3CJENi", "uri": "/contracts/fEJWd3CJENi#housemarks", "label": "Strategic Alliance Agreement (Theravance Inc)", "score": 21.0, "published": true}, {"hash": "4Qhb5dslhbC", "uri": "/contracts/4Qhb5dslhbC#housemarks", "label": "Strategic Alliance Agreement (Theravance Inc)", "score": 21.0, "published": true}], "size": 4, "hash": "686b856eb30c2022c108e6dbbf53dbcb", "id": 3}, {"snippet_links": [{"key": "licensee-shall", "type": "clause", "offset": [0, 14]}, {"key": "responsible-for", "type": "clause", "offset": [18, 33]}, {"key": "the-licensee", "type": "clause", "offset": [70, 82]}, {"key": "the-territory", "type": "clause", "offset": [105, 118]}, {"key": "expenses-associated", "type": "definition", "offset": [135, 154]}, {"key": "akebia-housemarks", "type": "definition", "offset": [238, 255]}], "snippet": "Licensee shall be responsible for the registration and maintenance of the Licensee Housemarks throughout the Territory, as well as all expenses associated therewith. Akebia shall be responsible for the registration and maintenance of the Akebia Housemarks throughout the Territory, as well as all expenses associated therewith.", "samples": [{"hash": "6YohvZ5ztjj", "uri": "/contracts/6YohvZ5ztjj#housemarks", "label": "Collaboration and License Agreement (Akebia Therapeutics, Inc.)", "score": 28.1759069131, "published": true}], "size": 3, "hash": "f5001837a31f4d2c94840f3372c9ec0c", "id": 4}, {"snippet_links": [{"key": "promotional-materials", "type": "clause", "offset": [0, 21]}, {"key": "packaging-and", "type": "clause", "offset": [30, 43]}, {"key": "the-product", "type": "clause", "offset": [64, 75]}, {"key": "in-the-field", "type": "clause", "offset": [76, 88]}, {"key": "in-the-united-states", "type": "clause", "offset": [89, 109]}, {"key": "novartis-housemarks", "type": "definition", "offset": [127, 146]}, {"key": "amgen-housemarks", "type": "definition", "offset": [155, 171]}, {"key": "equal-prominence", "type": "definition", "offset": [175, 191]}, {"key": "to-the-extent-allowed", "type": "clause", "offset": [192, 213]}, {"key": "applicable-law", "type": "clause", "offset": [217, 231]}, {"key": "in-accordance-with", "type": "definition", "offset": [236, 254]}, {"key": "the-applicable", "type": "clause", "offset": [255, 269]}, {"key": "commercialization-plan", "type": "definition", "offset": [270, 292]}, {"key": "provided-that", "type": "clause", "offset": [336, 349]}, {"key": "in-the-event", "type": "clause", "offset": [351, 363]}, {"key": "the-parties-shall", "type": "clause", "offset": [474, 491]}, {"key": "each-party-will", "type": "clause", "offset": [738, 753]}, {"key": "united-states-only", "type": "clause", "offset": [794, 812]}, {"key": "product-trademarks", "type": "clause", "offset": [832, 850]}, {"key": "amgen-product", "type": "definition", "offset": [854, 867]}], "snippet": "Promotional Materials and all packaging and package inserts for the Product in the Field in the United States will display the Novartis Housemarks and the Amgen Housemarks in equal prominence to the extent allowed by applicable Law and in accordance with the applicable Commercialization Plan, and to the extent reasonably practicable; provided that, in the event that it is not reasonably practicable to display the Novartis Housemarks on any packaging or package inserts, the Parties shall discuss such matter, and the Novartis Housemarks shall be displayed as soon as reasonably practicable. Except for the use of the Novartis Housemarks and the Amgen Housemarks as may be expressly set forth in the applicable Commercialization Plan, each Party will promote the Product in the Field in the United States only under the Novartis Product Trademarks or Amgen Product Trademarks, as applicable.", "samples": [{"hash": "l8QAlFKl7RU", "uri": "/contracts/l8QAlFKl7RU#housemarks", "label": "Collaboration Agreement", "score": 30.340862423, "published": true}, {"hash": "9f0OEZhx4lY", "uri": "/contracts/9f0OEZhx4lY#housemarks", "label": "Collaboration Agreement (Amgen Inc)", "score": 28.5646817248, "published": true}], "size": 2, "hash": "48c824181efccbd4dc8061a1ac6da2b3", "id": 5}, {"snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "goodwill-and-reputation", "type": "clause", "offset": [28, 51]}, {"key": "associated-with", "type": "definition", "offset": [66, 81]}, {"key": "other-party", "type": "definition", "offset": [86, 97]}, {"key": "the-owner", "type": "definition", "offset": [249, 258]}, {"key": "trademark-guidelines", "type": "definition", "offset": [261, 281]}, {"key": "with-respect-to", "type": "clause", "offset": [327, 342]}, {"key": "product-trademarks", "type": "clause", "offset": [365, 383]}, {"key": "licenses-granted", "type": "clause", "offset": [401, 417]}, {"key": "reasonable-precautions", "type": "clause", "offset": [477, 499]}, {"key": "diligent-efforts", "type": "definition", "offset": [691, 707]}, {"key": "reasonably-likely", "type": "definition", "offset": [746, 763]}, {"key": "certain-information", "type": "clause", "offset": [842, 861]}, {"key": "omitted-and-filed-separately-with-the-commission", "type": "clause", "offset": [871, 919]}, {"key": "confidential-treatment", "type": "definition", "offset": [921, 943]}], "snippet": "Each Party acknowledges the goodwill and reputation that has been associated with the other Party's Housemarks over the years, and shall use such Housemarks in a manner that maintains and promotes such goodwill and reputation and is consistent with the owner's trademark guidelines. In using the other Party's Housemarks (and, with respect to THERAVANCE, the MYLAN Product Trademarks) pursuant to the licenses granted in Sections 2.01 and 2.02 above, each Party shall (i) take reasonable precautions and actions to protect the goodwill and reputation that has inured to the other Party's Housemarks and MYLAN Product Trademarks, and (ii) refrain from doing any act that is intended, and use Diligent Efforts to refrain from doing any act that is reasonably likely, to impair the reputation of such Housemarks and MYLAN Product Trademarks. ***CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. \u200b", "samples": [{"hash": "hGDBtHhsDpe", "uri": "/contracts/hGDBtHhsDpe#housemarks", "label": "Development and Commercialization Agreement (Theravance Biopharma, Inc.)", "score": 32.1540041068, "published": true}], "size": 2, "hash": "3f9eb6c71c23efb9721f670d120ca11e", "id": 6}, {"snippet_links": [{"key": "licensee-will", "type": "clause", "offset": [0, 13]}, {"key": "licensed-product", "type": "clause", "offset": [32, 48]}, {"key": "product-marks", "type": "clause", "offset": [75, 88]}, {"key": "each-party", "type": "clause", "offset": [93, 103]}, {"key": "no-other-marks", "type": "clause", "offset": [142, 156]}], "snippet": "Licensee will Commercialize the Licensed Product only under the applicable Product Marks and each Party\u2019s Housemarks as set forth herein, and no other Marks.", "samples": [{"hash": "a9kRUB7pcWW", "uri": "/contracts/a9kRUB7pcWW#housemarks", "label": "License Agreement (Akebia Therapeutics, Inc.)", "score": 34.6536618754, "published": true}], "size": 2, "hash": "b18a7f80bb05d721838e69a4005b5b1b", "id": 7}, {"snippet_links": [{"key": "the-products", "type": "clause", "offset": [17, 29]}, {"key": "product-marks", "type": "clause", "offset": [56, 69]}, {"key": "each-party", "type": "clause", "offset": [74, 84]}, {"key": "no-other-marks", "type": "clause", "offset": [123, 137]}], "snippet": "ALJ will promote the Products only under the applicable Product Marks and each Party\u2019s Housemarks as set forth herein, and no other Marks.", "samples": [{"hash": "6vCatjZeJG8", "uri": "/contracts/6vCatjZeJG8#housemarks", "label": "Commercialization and License Agreement (Evelo Biosciences, Inc.)", "score": 32.2224503765, "published": true}], "size": 1, "hash": "b37b5f008e35c73e5a92dc5a533a900e", "id": 8}, {"snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "goodwill-and-reputation", "type": "clause", "offset": [28, 51]}, {"key": "associated-with", "type": "definition", "offset": [66, 81]}, {"key": "other-party", "type": "definition", "offset": [86, 97]}, {"key": "consistent-with", "type": "clause", "offset": [233, 248]}, {"key": "trademark-guidelines", "type": "definition", "offset": [249, 269]}, {"key": "reasonable-precautions", "type": "clause", "offset": [297, 319]}, {"key": "reasonably-likely", "type": "definition", "offset": [461, 478]}, {"key": "neither-party", "type": "definition", "offset": [598, 611]}, {"key": "with-respect-to", "type": "clause", "offset": [665, 680]}, {"key": "rights-to-sublicense", "type": "clause", "offset": [771, 791]}, {"key": "licensed-product", "type": "clause", "offset": [836, 852]}, {"key": "title-and-interest", "type": "clause", "offset": [878, 896]}, {"key": "all-intellectual-property-rights", "type": "clause", "offset": [937, 969]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [1030, 1048]}, {"key": "to-the-extent", "type": "clause", "offset": [1053, 1066]}, {"key": "comply-with", "type": "clause", "offset": [1103, 1114]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [1125, 1157]}, {"key": "for-example", "type": "definition", "offset": [1159, 1170]}, {"key": "the-licensor", "type": "definition", "offset": [1198, 1210]}, {"key": "in-accordance-with", "type": "definition", "offset": [1231, 1249]}], "snippet": "Each Party acknowledges the goodwill and reputation that has been associated with the other Party\u2019s Housemarks over the years, and shall use such Housemarks in a manner that maintains and promotes such goodwill and reputation and is consistent with trademark guidelines. Each Party shall take all reasonable precautions and actions to protect the goodwill and reputation that has inured to the other Party\u2019s Housemarks, shall refrain from doing any act that is reasonably likely to impair the reputation of such Housemarks, and shall cooperate fully to protect such Housemarks. To avoid any doubt, neither Party grants to the other any license, express or implied, with respect to any Housemarks; provided, however, that THERAVANCE hereby grants ASTELLAS a license (with rights to sublicense Affiliates, sublicenses and distributors of Licensed Product) under the entire right, title and interest in and to the THERAVANCE Housemarks and all intellectual property rights therein to use and display the THERAVANCE Housemarks solely for the purpose of and to the extent necessary or reasonably required to comply with ASTELLAS\u2019 obligations under this Agreement (for example, to identify THERAVANCE as the licensor of Licensed Product in accordance with Section 7.02).", "samples": [{"hash": "kwVDHqgxh7H", "uri": "/contracts/kwVDHqgxh7H#housemarks", "label": "License, Development and Commercialization Agreement (Theravance Inc)", "score": 21.0, "published": true}], "size": 1, "hash": "62c6acbd8544cca13b99a8ca59a06130", "id": 9}, {"snippet_links": [{"key": "the-parties", "type": "definition", "offset": [0, 11]}, {"key": "in-consultation-with", "type": "definition", "offset": [53, 73]}], "snippet": "The Parties, through the Europe JSC or the Asia JSC, in consultation with regulatory experts, will [***].", "samples": [{"hash": "8l1CLe4GvE0", "uri": "/contracts/8l1CLe4GvE0#housemarks", "label": "License Agreement (Ionis Pharmaceuticals Inc)", "score": 33.5817932923, "published": true}], "size": 1, "hash": "0a01b10ba356fdd1d5149ef97e480b1b", "id": 10}], "next_curs": "ClMSTWoVc35sYXdpbnNpZGVyY29udHJhY3Rzci8LEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhNob3VzZW1hcmtzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"title": "Housemarks", "size": 31, "parents": [["trademarks-and-housemarks", "Trademarks and Housemarks"], ["trademarks", "Trademarks"], ["rights-and-obligations", "Rights and Obligations"], ["required-use-and-compliance", "Required Use and Compliance"], ["commercialization", "COMMERCIALIZATION"]], "children": [["pharmacovigilance-agreement", "Pharmacovigilance Agreement"], ["data-security", "Data Security"], ["notice", "Notice"], ["product-withdrawals-and-limited-recalls", "Product Withdrawals and Limited Recalls"], ["safety-reporting-and-global-safety-database", "Safety Reporting and Global Safety Database"]], "id": "housemarks", "related": [["trade-marks", "Trade Marks", "Trade Marks"], ["trademarks", "Trademarks", "Trademarks"], ["proprietary-marks", "Proprietary Marks", "Proprietary Marks"], ["product-trademarks", "Product Trademarks", "Product Trademarks"], ["marks", "Marks", "Marks"]], "related_snippets": [], "updated": "2025-07-07T12:37:53+00:00", "also_ask": [], "drafting_tip": "", "explanation": "The Housemarks clause defines the rights and obligations of the parties regarding the use and protection of specific trademarks or brand identifiers associated with a business or property. Typically, this clause outlines which party owns the housemarks, how they may be used by the other party (such as in marketing or signage), and any restrictions on their use to maintain brand integrity. By clearly delineating these terms, the clause helps prevent unauthorized use or infringement of valuable brand assets, ensuring both parties understand their rights and responsibilities regarding the housemarks."}, "json": true, "cursor": ""}}